Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma
Pimozide is currently being used in clinic as a neuroleptic and exerts versatile biological actions. Pimozide is a cationic amphiphilic drug (CAD); CADs block the synthesis of neutral lipids, impair cholesterol homeostasis of cancer cells and increase accumulation of diacylglycerol-3-phosphate. Pimozide exerts tumoricidal activity which was first shown for melanoma and neuroblastoma via proposed anti- dopaminergic effects. Recently, pancreas cancers are shown to elevate dopamine receptor-2 synthesis, which is blocked by pimozide leading growth inhibition.
Source: Critical Reviews in Oncology Hematology - Category: Cancer & Oncology Authors: Ilhan Elmaci, Meric A. Altinoz Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Cholesterol | Employment | Hematology | Melanoma | Neuroblastoma | Neurology | Pancreas | Pancreatic Cancer | Schizophrenia | Skin Cancer